Dermatology

PRP in dermatology operates through two complementary mechanisms: direct growth factor stimulation of dermal fibroblasts and extracellular matrix remodeling, and synergistic enhancement of energy-based or microneedling procedures.

The strongest evidence exists for PRP combined with microneedling for acne scars. A 2024 network meta-analysis of 24 RCTs (1,546 patients) found laser plus PRP ranked best for reducing scar scores (SUCRA 98.4%), while microneedling plus PRP yielded 3 times higher odds of achieving more than 50% improvement versus microneedling alone. The combination works because microneedling creates microchannels that facilitate PRP absorption while triggering its own Wnt/beta-catenin wound-healing cascade.

For facial rejuvenation, the evidence is more nuanced. Histological studies consistently show increased collagen deposition following PRP treatment. However, the rigorous Pincelli et al. 2024 Mayo Clinic RCT found no significant improvement in skin laxity versus saline in women 45 years and older — a result that must be honestly acknowledged.

autologIX adds the protein enrichment dimension to dermatological applications. Concentrated fibronectin provides the provisional matrix for keratinocyte migration across treated skin. Concentrated fibrinogen serves as a sustained-release reservoir for growth factors, extending biological activity beyond the initial PRP bolus. Characterized exosomes carry cargo relevant to collagen synthesis and anti-inflammatory signaling. The higher volume (6–7 mL) accommodates full-face treatment protocols.

Clinical studies investigating autologIX outcomes for dermatology are in development.